Evidence map›Paper›PMID 20080467›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2010

Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment.

Carlos Ferrer Albiach, Antonio Conde Moreno, Marta Rodríguez Cordón, Virginia Morillo Macías, Ana Bouché Babiloni, Inmaculada Beato Tortajada, Angel Sánchez Iglesias, Alicia Francés Muñoz

Erratum issuedAbstract readEvaluation StudyReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.American journal of nuclear medicine and molecular imaging · 2014
    Review
  2. Non-FDG PET in oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2011
    Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors.

Carlos Ferrer AlbiachServicio de Oncología Radioterápica, Consorcio Hospitalario Provincial de Castellón, Castellón, Spain. ferreralbiach@gmail.com
Antonio Conde Moreno
Marta Rodríguez Cordón
Virginia Morillo Macías
Ana Bouché Babiloni
Inmaculada Beato Tortajada
Angel Sánchez Iglesias
Alicia Francés Muñoz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia is related to poor prognosis because it is associated to chemo- and radioresistance. During recent years the evolution of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring tumour hypoxia.

Indexed as

AnimalsBiomarkers, TumorFluorodeoxyglucose F18HumansHypoxiaImmunohistochemistryMolecular ImagingNeoplasmsPositron-Emission TomographyPrognosisRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedBiomarkers, TumorFluorodeoxyglucose F18

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.